Navigation Links
LA breast cancer activist honored with Survivor Circle Award
Date:10/16/2007

The American Society for Therapeutic Radiology and Oncology is pleased to announce that Stefanie LaRue of Woodland Hills, Calif., has been selected as the 2007 Survivor Circle Award winner. Ms. LaRue will be presented with her award and a $1,000 cash prize on Sunday, October 28, 2007, at 8:00 a.m. at the Los Angeles Convention Center during ASTROs 49th Annual Meeting, which will take place October 28 through November 1 in Los Angeles.

The Survivor Circle Award recognizes a person living with cancer in the Los Angeles metropolitan area who has devoted his or her time to helping others who are living with cancer in their community. Ms. LaRue was diagnosed with Stage-4 Advanced/Metastatic Breast Cancer in 2005 at the age of 30. Before receiving her diagnosis, she was misdiagnosed by three doctors who told her that she probably had a breast infection because she was too young and healthy to have breast cancer. Ms. LaRue now devotes her time to educating men as well as women and the medical and insurance communities about diagnosing breast cancer and preventing misdiagnoses in women under the age of 40.

It is always inspiring to see a person who is diagnosed with a very devastating type of cancer at a young age turn that experience into an opportunity to educate and help others who are in a similar situation Louis Harrison, M.D., a radiation oncologist at Beth Israel Medical Center in New York City and president of the Board of Directors for ASTRO.

Ms. LaRues dedication to her cause will hopefully raise awareness that breast cancer can strike at any age. According to the Young Survival Coalition, an international, nonprofit organization dedicated specifically to the issues and concerns of young women with breast cancer, there are more than 250,000 women in the U.S. under the age of 40 who are living with breast cancer; however, there is no effective screening tool for this age group.

Ms. LaRue founded the LaRue Foundation as a platform to build aware
'/>"/>

Contact: Beth Bukata
bethb@astro.org
703-839-7332
American Society for Therapeutic Radiology and Oncology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Ductal lavage may detect early breast cancer
4. Breast Feeding prevents obesity later on in life
5. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
6. Breast milk is essential
7. Exercise to Prevent Early Breast Cancer
8. Cholesterol Drugs Prevent Breast Cancer
9. Breastfeeding not found to have an impact on weight of the child.
10. Smoking and Breast Cancer - A Deadly Combination
11. The Use Of MRI For Screening Of Breast Cancer Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... LAKES, N.J., Nov. 21 To...edical intervention in treating 88 percent of pati... of Americans treated for a chronic condition acco...ng and 75 percent of all medical costs. A proprie... by Medco Health Solutions, Inc. (NYSE: MHS ) si...
(Date:11/21/2008)...nts in mice find running increases production of n...althDay News) -- In experiments in mice, exercise ...f brain stem cells usually seen with aging, Taiwan...ration of the brain,s ability to stave off aging a...a neurochemical that is essential for the producti...
(Date:11/21/2008)..., Nov. 21 /PRNewswire/ -- For the second year i..., McCann Healthcare Worldwide,s agency network wo...rk at the 22nd annual international RX Club Show. ...y offices won a total of 59 RX Club Awards of Exce...ng McCann Healthcare Worldwide agencies include Ca...
(Date:11/21/2008)...Nov. 21 Innerscope Research(TM), a...ializing in Emotional Response Measurement,annou... will strengthen the,company,s research and devel...es. , The three appointments, who deliver a...y Gill as Chief Financial Officer and Vice Preside...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...orn to women with high levels of lead in their bon... babies exposed to lead from sources like old pain...the journal Pediatrics, they said this type of lea... health problem, in view of the long residence tim...
...t with medications can reduce abdominal fat in peo...rsity of Texas have been looking into the effect t...2 diabetes.// They studied 10 people with the cond... After this time body weight had, on the whole, in...
...ect people who are at high risk of suffering a str...is cheap enough to be used by opticians and GPs to...cell death due to bleeding from damaged blood vess...e in high-risk patients are available, so doctors ...
...tective substances, produced by the body in stress... TB bacteria, researchers in the UK report. Accord...ature Medicine,// these heat-shock proteins, which...cells survive stressful times and bolster the immu...
Other Medicine News:
(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNe... today announced that the United States Food and D...val for PROMACTA(R) (eltrombopag) for the treatmen...une (idiopathic) thrombocytopenic purpura (ITP) wh...oids, immunoglobulins or splenectomy. The approval...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-F...hat the Anti-infective Drugs Advisory Committee of...voted 17 to 2 against the,approval of intravenous...for,the treatment of patients with complicated sk...ing those caused by methicillin-resistant Staphylo...
(Date:11/20/2008)...MERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ ...company will present results from the Phase 1B,cl...nced metastatic breast,cancer, BZL101, at the Soc...l,Conference in Atlanta, Georgia. The Company,s ...bstract and will be presented as a part of the Bes...
(Date:11/20/2008)...AMBRIDGE, Mass., Nov. 20 Radius He... an additional $15 million to its second instituti...vestment to $82.5 million and the total amount rai...n. All existing institutional investors participat...ic Fund and including MPM Capital, The Wellcome Tr...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 1Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 3Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 4Most Off Label Cancer Drug Use for Palliative Care 27727 1Most Off Label Cancer Drug Use for Palliative Care 27727 2The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U S 27723 1The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U S 27723 2Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 27719 1Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 27719 2
...ique suggests how lithium works as a,therapeutic ,...CLA have shown,that lithium, long the standard tre...of gray matter in the brains of patients with,the ...issue of the journal,Biological Psychiatry and is ...clinical neuropsychologist and assistant,professor...
... Oncology Portfolio, SOUTH SAN FRANCISCO, Calif., ...rmaceuticals, Inc. today,announced the presentatio...mall molecule inhibitors of select kinases as,pote...d other,disorders. Rigel scientists will give the ...th to 18th (see list below) at the,upcoming meetin...
Other Medicine Technology:UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 2UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 3Rigel to Present New Research Programs at AACR Meeting 2Rigel to Present New Research Programs at AACR Meeting 3Rigel to Present New Research Programs at AACR Meeting 4Rigel to Present New Research Programs at AACR Meeting 5
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
...e PhD System has the flexibility to accommodate EI...s with low to high volume workloads, the unique mo...g. Through networking, one to ten workstations can...ers can switch a single workstation from EIA to IF...
...idelberg Engineering GmbH, the leading developer o...nnounced the introduction of the Heidelberg Retina...ts flagship product for the assessment, diagnosis ...ssor, the HRT3 uses laser technology to produce a ...
Medicine Products: